A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer

Clinical trial NCT01935453 · COMPLETED

Trial details

NCT number: NCT01935453
Sponsor: OrienGene Biotechnology Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Liver Cancer Pancreatic Cancer Lung Cancer

Start date: 2012-05-01
Primary completion: 2014-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.